TATE.L

Tate & Lyle Plc
Tate & Lyle PLC - Transaction in Own Shares
31st October 2024, 17:28
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4917K
Tate & Lyle PLC
31 October 2024
 

Transactions in Own Securities

 


31 October 2024


Tate & Lyle plc (the "Company") announces that it has purchased the following number of its ordinary shares from Merrill Lynch International ("BofA") as part of its share buyback programme announced on 20 June 2024 (the "Programme").







Date of purchase:

31 October 2024


Number of ordinary shares of £0.2916666667 each purchased:

324,513


Highest price paid per share (£):

7.53


Lowest price paid per share (£) :

7.46


Volume weighted average price paid per share (£):

7.50







The repurchased shares will be held in treasury. Following the purchase of these shares, the Company holds 22,175,740 of its ordinary shares in treasury and has 379,546,993 ordinary shares in issue (excluding treasury shares).







Aggregated Information

 








Date

Trading venue

Volume weighted average price (£ per share)

Number of Shares Purchased

 

31 October 2024

London Stock Exchange

7.50

272,687


31 October 2024

Chi-X (CXE)

7.50

41,651


31 October 2024

BATS (BXE)

7.50

10,175







Transaction Details

 








In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by BofA on behalf of the Company as part of the Programme is detailed on the attached:


http://www.rns-pdf.londonstockexchange.com/rns/4917K_1-2024-10-31.pdf

 






The LEI reference for Tate & Lyle PLC is 2138008K14474WPKZ244.








For further information please contact:









Christopher Marsh, VP, Investor Relations


Mobile: +44 (0)7796 192 688







Nick Hasell (FTI Consulting), Media Relations


Mobile: +44 (0)7825 523 383


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMBBRTMTTJBRI]]>
TwitterFacebookLinkedIn